This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Pituitary gland, craniopharyngeal duct
CD2_BENIGN_PITUITARY_CRANIPHAR_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Pituitary gland, craniopharyngeal duct
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Pituitary gland, craniopharyngeal duct
- Benign neoplasm of other and unspecified endocrine glands
- Benign neoplasm of other and unspecified endocrine glands
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1958 | 1142 | 816 |
| Unadjusted period prevalence (%) | 0.38 | 0.39 | 0.36 |
| Median age at first event (years) | 50.74 | 46.87 | 56.15 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1736
- Matched controls
- 17359
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB09
ATC
hydrocortisone; systemic
89.6
323.0
605
103
N04BC06
ATC
cabergoline; oral (dopamine agonists)
192.9
323.0
329
21
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
7811.1
323.0
554
*
E22.1
ICD-10 Finland
Hyperprolactinaemia
121.7
323.0
388
41
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
4503599627370496.0
323.0
1510
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
254.2
323.0
330
16
E23.00
ICD-10 Finland
Panhypopituitarism
578.8
323.0
331
7
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
388.9
323.0
699
30
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
858.3
234.1
225
*
D35.31
ICD-10 Finland
Cyst in Rathke's pocket
+∞
213.0
200
*
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
461.1
170.8
168
*
H03AA01
ATC
levothyroxine sodium; systemic
4.7
166.5
728
2302
ZXC86
NOMESCO Finland
Use of endoscopic device
101.0
158.5
173
19
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
1535.0
145.9
140
*
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
1439.5
138.4
133
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
9.0
133.7
303
398
G02CB01
ATC
bromocriptine; systemic
20.3
131.7
202
112
XCK00
NOMESCO Finland
Perimetry
7.5
127.7
328
523
102
Kela drug reimbursment
Diabetes insipidus
165.2
117.9
123
8
H53.4
ICD-10 Finland
Visual field defects
16.4
109.5
181
122
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
16.7
103.6
170
112
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.2
99.7
294
555
2273A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)
+∞
96.8
92
*
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
10.4
95.4
195
208
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.8
94.3
478
1577
G02CB03
ATC
cabergoline; oral (prolactine inhibitors)
92.1
94.2
104
12
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
460.4
89.0
88
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
10.3
83.5
171
182
E23.05
ICD-10 Finland
Lack of TSH
66.1
81.5
94
15
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
9.0
77.1
170
206
D35.30
ICD-10 Finland
Craniopharyngoma
+∞
76.6
73
*
H02AB02
ATC
dexamethasone; systemic
19.0
76.5
119
67
ZXC95
NOMESCO Finland
Use of surgical navigator
23.3
68.3
99
45
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.4
66.7
383
1349
C61
ICD-10 Finland
Malignant neoplasm of prostate
339.5
65.9
66
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
63.9
61
*
130
Kela drug reimbursment
Malignant tumour
+∞
62.9
60
*
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
22.3
59.3
87
41
2542
FHL
Transasal hypophysectomy
+∞
58.7
56
*
E23.2
ICD-10 Finland
Diabetes insipidus
52.0
58.5
70
14
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
57.1
523
2462
WF002
NOMESCO Finland
Radical radiotherapy
67.4
56.6
65
10
H01AC01
ATC
somatropin; parenteral
192.7
54.3
56
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
53.4
51
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
136.5
50.1
53
*
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
42.7
50.0
62
15
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.7
48.4
229
679
E24.0
ICD-10 Finland
Pituitary-dependent Cushing disease
171.4
48.1
50
*
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
10.7
46.7
92
90
PJA12
NOMESCO Finland
Sentinel node biopsy
85.8
45.1
50
6
115
Kela drug reimbursment
Breast cancer
+∞
45.0
43
*
CS494
NOMESCO Finland
Other visual field testing
8.2
44.4
102
131
301
Kela drug reimbursment
Growth hormone
+∞
43.9
42
*
E89.30
ICD-10 Finland
Postprocedural hypopituitarism
+∞
43.9
42
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
34.0
43.1
56
17
H01CB02
ATC
octreotide; parenteral
+∞
42.9
41
*
AA1AD
NOMESCO Finland
CT of head and brain
2.3
42.0
457
2293
H01CB03
ATC
lanreotide; parenteral
+∞
40.8
39
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
40.8
39
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
12.6
40.4
73
60
22620
ICD-8 Finland
Benign neoplasm of endocrine glands, Pituitary gland and craniopharyngeal duct (pouch)
+∞
38.7
37
*
E23.03
ICD-10 Finland
Lack of ACTH
64.4
38.2
44
7
A04AA02
ATC
granisetron; systemic, transdermal
104.9
37.9
41
*
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
136.3
37.9
40
*
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
16.7
37.4
60
37
9350/1-C75.2
ICD-O-3
Craniopharyngioma, NOS, of craniopharyngeal duct
+∞
36.6
35
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.4
36.2
139
339
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.0
35.9
226
820
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
53.7
35.5
42
8
A03FA01
ATC
metoclopramide; systemic, rectal
2.6
32.1
263
1119
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
13.8
31.9
55
41
JN4BD
NOMESCO Finland
Extensive body CT
4.2
31.8
128
326
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
31.8
674
4367
R51.80
ICD-10 Finland
Headache
2.4
31.7
316
1492
WX402
NOMESCO Finland
General anaesthesia
2.5
31.7
279
1233
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
31.7
357
1789
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
31.3
30
*
116
Kela drug reimbursment
Prostate cancer
+∞
31.3
30
*
E23.6
ICD-10 Finland
Other disorders of pituitary gland
71.2
31.0
35
5
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
30.3
29
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.7
30.2
228
925
E22.9
ICD-10 Finland
Hyperfunction of pituitary gland, unspecified
+∞
29.2
28
*
2370A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Pituitary gland and craniopharyngeal duct
+∞
29.2
28
*
WX882
NOMESCO Finland
High dependency care
6.1
29.2
81
137
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.9
29.0
188
691
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
296.6
28.9
29
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
81.5
28.8
32
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.8
28.7
98
212
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
9.4
28.3
59
65
HAC20
NOMESCO Finland
Total mastectomy
101.7
27.7
30
*
G02CB04
ATC
quinagolide; oral
54.3
27.2
32
6
E24.9
ICD-10 Finland
Cushing syndrome, unspecified
76.4
26.8
30
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.9
26.6
114
308
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.2
26.0
141
460
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.4
25.4
227
1005
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
58.9
25.0
29
5
H47.2
ICD-10 Finland
Optic atrophy
16.3
25.0
40
25
A04AA01
ATC
ondansetron; systemic, rectal
5.6
24.8
74
138
E23
ICD-10 Finland
Hypofunction and other disorders of pituitary gland
253.6
24.7
25
*
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
7.3
24.4
59
83
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
24.0
23
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.7
24.0
70
127
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.0
23.3
97
255
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
6.1
23.1
64
109
WX110
NOMESCO Finland
Local anesthesy
1.7
22.7
1144
9287
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
121.6
22.6
24
*
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
121.6
22.6
24
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
21.9
21
*
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
222.6
21.6
22
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
116.4
21.6
23
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
20.9
20
*
25320
ICD-8 Finland
Diseases of pituitary gland, Chromophobe adenoma, pituitary
+∞
20.9
20
*
UJF32
NOMESCO Finland
Coloscopy
1.9
20.8
383
2295
WF003
NOMESCO Finland
Adjuvant radiotherapy
77.7
20.7
23
*
E23.08
ICD-10 Finland
Hypopituitarism
212.3
20.6
21
*
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
25.8
20.4
28
11
Y28
ICPC
Limited function/disability (Y)
20.3
20.4
30
15
A02BC02
ATC
pantoprazole; systemic
1.6
20.1
1014
8094
N02BE01
ATC
paracetamol; systemic, rectal
1.8
20.0
1408
12300
ZX050
NOMESCO Finland
Stereotactic radiotherapy
58.2
19.9
23
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
12.7
19.9
35
28
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
+∞
19.8
19
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
202.1
19.6
20
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
8.2
19.0
42
52
L01BC06
ATC
capecitabine; oral
+∞
18.8
18
*
E23.0
ICD-10 Finland
Hypopituitarism
+∞
18.8
18
*
R42
ICD-10 Finland
Dizziness and giddiness
1.8
18.8
355
2138
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
70.6
18.7
21
*
T99
ICPC
Endocr/metab/nutrit disease other
6.1
18.7
51
86
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
191.9
18.6
19
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
191.9
18.6
19
*
ZXA10
NOMESCO Finland
Bilateral
1.9
18.3
293
1664
ZX120
NOMESCO Finland
Intravenous
2.7
18.3
127
487
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.5
18.2
54
101
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
18.1
447
2924
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
33.3
18.0
23
7
105
Kela drug reimbursment
Adrenal cortical hypofunction
27.0
17.8
24
9
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.4
17.8
89
274
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
17.7
17
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
17.7
17
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
17.7
17
*
2530A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Acromegaly and gigantism[ACROMEGALIA]
+∞
17.7
17
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
96.0
17.6
19
*
E23.7
ICD-10 Finland
Disorder of pituitary gland, unspecified
96.0
17.6
19
*
UDM02
NOMESCO Finland
Sinoscopy
4.2
17.6
67
164
121
Kela drug reimbursment
Severe hypofunction of sexual glands
5.6
17.4
51
94
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
14.0
17.3
29
21
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
17.2
427
2790
NK6AN
NOMESCO Finland
Total body bone isotope imaging
31.8
17.0
22
7
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
16.9
424
2778
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
16.7
655
4829
G47.3
ICD-10 Finland
Sleep apnoea
1.8
16.6
354
2203
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
171.5
16.5
17
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
16.2
648
4784
N91.1
ICD-10 Finland
Secondary amenorrhoea
4.6
16.2
56
125
HAB40
NOMESCO Finland
Wedge excision of mammary gland
11.8
16.0
29
25
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
5.0
16.0
51
104
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
15.6
15
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
15.6
15
*
AA4DM
NOMESCO Finland
Very extensive MRI examination of sella turcica with 3 Tesla magnet
+∞
15.6
15
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
15.6
15
*
TAB00
NOMESCO Finland
Lumbar puncture
2.9
15.5
96
344
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
161.3
15.5
16
*
D35.9
ICD-10 Finland
Benign neoplasm: Endocrine gland, unspecified
161.3
15.5
16
*
G44.2
ICD-10 Finland
Tension-type headache
1.9
15.1
232
1292
UKC02
NOMESCO Finland
Cystoscopy
2.0
15.1
207
1105
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.5
15.0
44
82
J01DB01
ATC
cefalexin; oral
1.6
14.9
1347
11893
N04BC01
ATC
bromocriptine; oral
57.2
14.8
17
*
WF099
NOMESCO Finland
Other radiotherapy
57.2
14.8
17
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.2
14.6
153
728
2159
FHL
Other measure in this category
+∞
14.6
14
*
H47.4
ICD-10 Finland
Disorders of optic chiasm
+∞
14.6
14
*
D352, E221
ICD-10 Finland
NA
+∞
14.6
14
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
14.6
14
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
36.3
14.4
18
5
-50
ICPC
Medication/prescr/renewal
3.1
14.2
79
264
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
14.2
140
646
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.4
13.8
49
113
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
20.2
13.8
20
10
L02AE02
ATC
leuprorelin; implant, parenteral
6.5
13.7
35
55
L02BA01
ATC
tamoxifen; oral
75.7
13.6
15
*
L02BB03
ATC
bicalutamide; oral
+∞
13.6
13
*
D35.3
ICD-10 Finland
Benign neoplasm: Craniopharyngeal duct
+∞
13.6
13
*
2532A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Panhypopituitarism[PANHYPOPITUITARISMUS]
+∞
13.6
13
*
V04CD01
ATC
metyrapone; oral
+∞
13.6
13
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
13.6
13
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
13.6
13
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
13.6
13
*
2531A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Other and unspecified anterior pituitary hyperfunction[HYPERPROLACTINAEMIA]
141.0
13.5
14
*
E27.2
ICD-10 Finland
Addisonian crisis
50.4
12.8
15
*
WZC30
NOMESCO Finland
Teaching
2.0
12.8
162
835
T73
ICPC
Neoplasm endocrine other/unspecified
70.4
12.6
14
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
12.6
260
1597
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
12.5
12
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
12.5
12
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
12.5
12
*
JN4AD
NOMESCO Finland
Body CT examination
3.4
12.5
60
181
H02AA02
ATC
fludrocortisone; oral
8.8
12.5
26
30
Y77
ICPC
Malignant neoplasm prostate
130.9
12.4
13
*
D35.1
ICD-10 Finland
Benign neoplasm: Parathyroid gland
14.4
12.3
20
14
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
12.2
200
1137
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
26.9
12.0
16
6
L02BG04
ATC
letrozole; oral
4.1
11.9
45
111
N75
ICPC
Benign neoplasm nervous system
47.0
11.9
14
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
11.8
129
626
A55
ICPC
General and Unspecified, Local injection/infiltration
7.4
11.7
27
37
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
65.4
11.6
13
*
A04AD12
ATC
aprepitant; systemic
65.4
11.6
13
*
D35.50
ICD-10 Finland
Carotid body
+∞
11.5
11
*
E89.39
ICD-10 Finland
Postprocedural hypopituitarism, other or several procedures
+∞
11.5
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
11.5
11
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
120.7
11.4
12
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
4.7
11.4
38
83
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
11.4
321
2145
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
8.9
11.3
23
26
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
6.0
11.2
30
51
ZZR00
NOMESCO Finland
Flap of skin
8.1
11.1
24
30
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
14.0
11.0
18
13
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
43.6
10.9
13
*
R53
ICD-10 Finland
Malaise and fatigue
1.6
10.9
297
1963
HA1AA
NOMESCO Finland
X-ray mammography
3.2
10.8
55
175
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
7.2
10.8
25
35
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
10.5
786
6433
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
10.5
273
1780
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
10.5
122
608
G03DB01
ATC
dydrogesterone; oral
1.7
10.4
210
1275
E22.2
ICD-10 Finland
Syndrome of inappropriate secretion of antidiuretic hormone
110.6
10.4
11
*
AA4BM
NOMESCO Finland
MRI examination of sella turcica with 3 Tesla magnet
+∞
10.4
10
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
10.4
10
*
AA4AD
NOMESCO Finland
CT of sella turcica
+∞
10.4
10
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
10.4
10
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
10.4
10
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
10.4
10
*
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
5.7
10.4
29
52
SPAT1153
SPAT
Removal of sutures
1.5
10.3
443
3253
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
9.6
10.3
20
21
R06.0
ICD-10 Finland
Dyspnoea
1.5
10.2
336
2329
E24.8
ICD-10 Finland
Other Cushing syndrome
40.3
10.0
12
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
9.9
198
1198
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
9.8
257
1680
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
26.2
9.8
13
5
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
9.7
230
1461
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.1
9.6
106
516
A02BC01
ATC
omeprazole; systemic
1.5
9.6
392
2847
J01MA02
ATC
ciprofloxacin; systemic
1.4
9.6
540
4177
B01AB10
ATC
tinzaparin; parenteral
2.6
9.6
69
275
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.3
9.5
47
147
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
9.5
150
842
R51
ICD-10 Finland
Headache
2.2
9.5
94
439
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.1
9.5
112
564
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
9.4
107
528
2397A
ICD-9 Finland
Neoplasm of unspecified nature, Endocrine glands and other parts of nervous system
100.5
9.4
10
*
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
30.2
9.4
12
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
9.4
9
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
9.4
9
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
9.4
9
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
9.4
9
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
9.4
9
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
9.4
9
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
9.4
9
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
+∞
9.4
9
*
N64.3
ICD-10 Finland
Galactorrhoea not associated with childbirth
10.7
9.3
17
16
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.5
9.3
42
123
ZX114
NOMESCO Finland
Intramuscular
5.1
9.3
28
56
H53.2
ICD-10 Finland
Diplopia
2.8
9.2
59
219
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.7
9.2
182
1098
JN4CD
NOMESCO Finland
Very extensive body CT
4.6
9.1
30
66
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
11.5
9.1
16
14
E03.89
ICD-10 Finland
Other specified hypothyroidism
2.8
9.0
57
209
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
36.9
9.0
11
*
S18
ICPC
Laceration/cut
1.4
8.9
569
4493
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.2
8.8
44
139
N02AA05
ATC
oxycodone; systemic
1.8
8.8
139
781
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.5
8.8
64
257
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.8
8.8
53
191
TQW99
NOMESCO Finland
Other minor procedure on skin
2.8
8.7
55
201
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.7
8.7
28
60
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
50.2
8.7
10
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
8.7
405
3015
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
8.6
172
1039
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
8.5
166
998
R11
ICD-10 Finland
Nausea and vomiting
2.0
8.5
113
596
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
27.6
8.5
11
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
90.4
8.4
9
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
90.4
8.4
9
*
E66.8
ICD-10 Finland
Other obesity
2.1
8.4
91
444
R50.9
ICD-10 Finland
Fever, unspecified
1.7
8.4
181
1123
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.3
8
*
D352, E220
ICD-10 Finland
NA
+∞
8.3
8
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
8.3
8
*
2550C
ICD-9 Finland
Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING E HYPERSECRETIO HYPOFYSEOS]
+∞
8.3
8
*
L01AX03
ATC
temozolomide; systemic
+∞
8.3
8
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
8.3
8
*
M14.5*E22.0
ICD-10 Finland
Arthropathy associated with acromegaly
+∞
8.3
8
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
8.3
8
*
2549
FHL
NA
+∞
8.3
8
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
8.3
8
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
8.3
8
*
E2300, D352
ICD-10 Finland
NA
+∞
8.3
8
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
8.3
8
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
8.3
8
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
8.3
8
*
AA4BD
NOMESCO Finland
Extensive CT of sella turcica
+∞
8.3
8
*
XKD00
NOMESCO Finland
Uroflowmetry
1.7
8.3
171
1046
D70.82
ICD-10 Finland
Drug-induced neutropenia
10.8
8.3
15
14
L57.0
ICD-10 Finland
Actinic keratosis
2.1
8.2
87
419
S10
ICPC
Boil/carbuncle
2.2
8.2
82
384
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
4.1
8.2
30
74
C08CA01
ATC
amlodipine; oral
1.4
8.2
455
3495
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.4
8.1
38
115
104
Kela drug reimbursment
Thyroid insufficiency
2.0
8.1
100
514
R55
ICD-10 Finland
Syncope and collapse
1.7
8.1
152
904
XJH00
NOMESCO Finland
Transanal ultrasonography
2.3
8.1
69
302
ZZC00
NOMESCO Finland
Graft of fascia
33.5
8.1
10
*
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
33.5
8.1
10
*
L03AA02
ATC
filgrastim; parenteral
17.2
8.1
12
7
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
11.7
8.1
14
12
H53.1
ICD-10 Finland
Subjective visual disturbances
2.0
8.0
99
510
N03AX14
ATC
levetiracetam; systemic
3.1
8.0
42
139
SPAT1263
SPAT
Sampling
1.4
8.0
638
5207
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
3.4
7.9
36
107
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
7.9
770
6479
A06AD11
ATC
lactulose; oral
1.7
7.8
168
1040
J01MA12
ATC
levofloxacin; systemic
1.6
7.8
230
1548
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
7.8
172
1072
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
3.6
7.8
33
93
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
7.7
210
1384
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
45.2
7.7
9
*
R93.0
ICD-10 Finland
Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
15.1
7.7
12
8
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
4.6
7.7
25
55
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
7.6
274
1927
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
11.9
7.6
13
11
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.8
7.6
46
168
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
80.4
7.4
8
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
80.4
7.4
8
*
D35.6
ICD-10 Finland
Benign neoplasm: Aortic body and other paraganglia
80.4
7.4
8
*
WF004
NOMESCO Finland
Palliative radiotherapy
80.4
7.4
8
*
R5140
NOMESCO Finland
Monitoring the use of the aid
1.7
7.4
147
889
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
7.3
92
477
XW000
NOMESCO Finland
Bone marrow biopsy
3.0
7.3
40
137
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
7.3
7
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
7.3
7
*
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
+∞
7.3
7
*
9350/1-C75.1
ICD-O-3
Craniopharyngioma, NOS, of pituitary gland
+∞
7.3
7
*
E24.1
ICD-10 Finland
Nelson syndrome
+∞
7.3
7
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
7.3
7
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
7.3
7
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
7.3
7
*
2535A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Diabetes insipidus
+∞
7.3
7
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
7.3
7
*
L02AE04
ATC
triptorelin; parenteral
+∞
7.3
7
*
E22
ICD-10 Finland
Hyperfunction of pituitary gland
+∞
7.3
7
*
H01AX01
ATC
pegvisomant; parenteral
+∞
7.3
7
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
7.3
7
*
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
10.9
7.3
13
12
E21.0
ICD-10 Finland
Primary hyperparathyroidism
3.9
7.3
28
73
ZZR10
NOMESCO Finland
Flap of skin and muscle
30.1
7.1
9
*
XCH00
NOMESCO Finland
Eye pressure measurement
2.4
7.1
56
234
SPAT1254
SPAT
Administration of medicine
1.6
7.1
202
1343
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
7.1
115
652
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
7.1
164
1037
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.8
7.1
119
686
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
6.0
7.1
18
30
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
3.2
7.1
35
112
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
7.0
512
4099
B01AB05
ATC
enoxaparin; parenteral
1.4
7.0
349
2620
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
3.6
7.0
29
81
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
6.9
415
3212
DFF00
NOMESCO Finland
Pure tone audiometry
1.8
6.9
119
691
A02BC05
ATC
esomeprazole; systemic
1.3
6.9
567
4623
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.2
6.9
63
286
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.5
6.8
254
1795
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
6.8
670
5603
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.6
6.8
45
173
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.6
6.8
187
1236
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
9.3
6.8
13
14
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
40.2
6.8
8
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
40.2
6.8
8
*
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
40.2
6.8
8
*
JN3AD
NOMESCO Finland
Abdominal CT examination
1.9
6.7
95
516
SPAT1301
SPAT
No procedures
1.4
6.7
451
3560
XCK10
NOMESCO Finland
Photography of fundus of eye
1.7
6.7
139
852
R31
ICD-10 Finland
Unspecified haematuria
1.8
6.7
108
614
Y99
ICPC
Genital disease male other
22.6
6.7
9
*
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
22.6
6.7
9
*
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
5.9
6.6
17
29
106
Kela drug reimbursment
Hypoparathyroidism
12.3
6.6
11
9
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.7
6.6
140
867
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
3.9
6.6
25
65
XA800
NOMESCO Finland
Neuropsychological investigation
2.1
6.5
69
336
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
6.5
554
4535
Z51.5
ICD-10 Finland
Palliative care
3.3
6.5
30
92
G04CA02
ATC
tamsulosin; oral
1.5
6.5
244
1730
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.6
6.5
179
1186
XX9XW
NOMESCO Finland
NA
5.3
6.5
18
34
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
70.1
6.4
7
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
70.1
6.4
7
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
70.1
6.4
7
*
N76
ICPC
Neoplasm nervous system unspecified
70.1
6.4
7
*
H35.20
ICD-10 Finland
Proliferative vitreoretinopathy
70.1
6.4
7
*
X76
ICPC
Malignant neoplasm breast female
70.1
6.4
7
*
25300
ICD-8 Finland
Diseases of pituitary gland, Aeromegalia
70.1
6.4
7
*
BCA30
NOMESCO Finland
Unilateral adrenalectomy
14.4
6.4
10
7
T28
ICPC
Limited function/disability (T)
4.1
6.4
23
57
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.9
6.4
96
531
N02AX02
ATC
tramadol; systemic, rectal
1.3
6.3
561
4612
R20.2
ICD-10 Finland
Paraesthesia of skin
1.8
6.3
97
543
E220, D352
ICD-10 Finland
NA
+∞
6.3
6
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
6.3
6
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
6.3
6
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
6.3
6
*
E27.5
ICD-10 Finland
Adrenomedullary hyperfunction
+∞
6.3
6
*
M35.2
ICD-10 Finland
Behçet disease
+∞
6.3
6
*
E24
ICD-10 Finland
Cushing syndrome
+∞
6.3
6
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
6.3
6
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
25310
ICD-8 Finland
Diseases of pituitary gland, Panhypopituitarismus
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
6.3
6
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
6.3
6
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
6.2
375
2905
K02.1
ICD-10 Finland
Caries of dentine
1.3
6.2
863
7541
G93.0
ICD-10 Finland
Cerebral cysts
6.3
6.2
15
24
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.7
6.1
110
647
R01AD08
ATC
fluticasone; nasal
1.3
6.1
415
3278
A28
ICPC
Limited function/disability NOS
1.6
6.0
161
1057
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
6.0
329
2504
ZX112
NOMESCO Finland
Subcutaneous
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1001
106
192.16
307.65
3.2
1.7
17.1
20.3
nmol/l
2.63
988
97
1143
651
40.78
307.65
4.6
1.4
381.6
294.0
mu/l
2.65
1119
584
204
22
103.40
307.65
2.3
1.3
—
—
—
0
0
604
448
19.05
307.65
2.0
1.3
7.1
9.2
u/l
2.32
497
368
685
1054
9.46
307.65
5.3
2.2
12.4
13.9
nmol/l
4.27
659
941
1418
1364
35.07
307.65
5.6
1.7
348.6
366.4
nmol/l
1.53
1376
1245
457
795
7.19
263.29
1.9
1.3
19.5
24.8
iu/l
2.52
371
677
178
83
23.49
242.59
1.4
2.1
—
—
—
0
0
220
227
10.79
193.61
1.9
1.5
0.3
0.4
nmol/l
0.88
158
195
137
58
25.32
193.39
2.5
1.7
2.9
6.1
nmol/l
0.42
114
45
303
507
6.89
178.10
2.9
1.8
41.5
40.5
nmol/l
0.19
298
484
416
945
5.32
176.99
3.2
3.1
4.3
4.6
pmol/l
3.23
390
830
169
135
13.61
175.51
2.3
1.3
285.4
279.2
mosm/kgh2o
1.66
156
100
254
363
7.89
172.40
3.0
1.9
172.9
209.1
pmol/l
3.60
241
345
1155
6148
3.14
132.51
6.7
5.2
1.2
1.2
mmol/l
0.06
1081
5474
1789
12563
5.91
129.90
7.8
3.9
14.9
14.6
pmol/l
4.64
1746
11553
1228
6872
3.11
126.89
7.4
5.5
1.2
1.2
mmol/l
0.47
1040
5831
251
646
4.31
88.65
5.2
10.1
24.1
24.3
mmol/l
0.62
245
595
401
1440
3.24
86.22
6.3
7.7
0.8
1.2
mmol/l
1.58
283
1098
402
1456
3.22
85.12
6.3
7.6
15.3
11.9
kpa
16.97
381
1388
402
1456
3.22
85.12
6.3
7.6
5.1
5.1
kpa
0.33
382
1388
1317
8664
2.59
83.51
5.8
4.3
6.5
6.7
mmol/l
4.41
1261
8001
380
1586
2.73
60.60
5.5
6.4
105.0
104.3
mmol/l
2.43
372
1551
119
227
5.52
59.79
2.2
1.3
16.1
22.2
u/l
1.52
110
177
1804
14941
3.64
57.07
7.2
4.6
1.5
2.0
mu/l
5.18
1701
13832
912
5810
2.07
52.57
4.9
3.9
35.6
36.3
g/l
3.43
860
5383
1461
11417
2.10
43.85
7.7
5.4
75.4
74.4
u/l
0.42
1388
10631
939
6324
1.93
43.50
2.8
2.3
76.9
76.1
nmol/l
0.38
869
5702
1014
7027
1.92
42.86
5.7
3.9
10.5
11.5
umol/l
3.65
956
6584
129
348
3.90
42.07
1.5
1.3
161.6
31.9
e6/l
0.66
100
279
129
348
3.90
42.07
1.5
1.4
1437.6
1293.9
e6/l
0.06
104
293
1864
16341
3.93
41.78
21.9
12.9
140.0
139.7
mmol/l
4.67
1852
15904
1865
16403
3.88
40.57
21.8
12.9
3.9
4.0
mmol/l
14.81
1849
15937
72
131
5.67
37.98
1.8
1.6
—
—
—
0
0
392
2081
2.10
34.54
1.8
2.0
29.3
29.8
s
0.90
377
2008
263
1187
2.40
34.37
8.1
8.4
126.4
124.0
g/l
1.17
248
1142
1121
8436
1.77
32.49
8.2
6.7
4.1
4.2
e9/l
0.84
1005
7315
1735
15042
2.35
32.22
16.4
9.9
84.6
84.0
ml/min/173m2
0.51
1559
12103
231
1018
2.44
31.72
3.7
2.8
1.2
1.2
mmol/l
0.00
210
844
192
775
2.64
31.70
6.7
9.7
0.7
0.7
%
1.12
192
770
334
1733
2.12
30.97
5.5
5.4
1.0
1.0
mmol/l
1.76
324
1605
122
394
3.24
30.19
1.3
1.2
530.4
471.6
mg/l
0.75
116
368
46
67
7.01
30.17
2.0
1.9
—
—
—
0
0
924
6707
1.72
29.31
4.3
3.7
—
—
—
0
0
527
3265
1.84
28.94
2.7
2.0
—
—
—
0
0
687
4605
1.76
28.93
2.1
2.1
192.8
232.1
u/l
0.49
648
4333
366
2016
2.00
28.67
3.6
2.8
0.8
0.8
mmol/l
0.20
347
1869
110
348
3.29
28.14
1.2
1.2
3.4
3.8
mmol/l
4.08
99
322
70
175
4.11
25.32
1.5
1.4
321.2
327.8
pmol/l
0.05
55
127
1407
11681
1.73
25.15
4.3
4.0
11.4
10.7
mm/h
1.13
1333
10852
1871
17152
3.04
24.68
20.8
12.5
77.5
75.6
umol/l
1.69
1871
17144
652
4466
1.69
24.47
3.3
2.0
2.3
2.4
mmol/l
0.47
579
3833
1786
16059
2.28
23.99
15.9
11.2
20.4
21.7
mg/l
1.10
1501
12289
615
4193
1.68
23.25
3.3
2.9
112.5
71.6
e6/l
0.62
486
3179
571
3829
1.69
22.92
3.3
2.8
0.3
0.4
e6/l
0.08
442
2847
317
1794
1.92
22.52
2.3
2.5
22.8
24.0
%
0.84
278
1531
937
7139
1.60
22.40
3.1
2.8
110.5
107.1
ug/l
0.26
874
6650
334
1968
1.84
20.80
2.3
2.4
2.3
2.4
g/l
0.54
307
1827
551
3744
1.66
20.65
2.2
2.2
2.9
2.8
mg/l
0.54
486
3190
147
641
2.40
20.48
3.8
1.5
100.2
3.2
ug/l
0.85
111
482
1214
9995
1.56
19.56
4.8
4.0
2618.8
1897.8
e6/l
0.14
17
124
214
1129
2.01
18.49
6.6
7.1
1.2
1.4
mmol/l
2.72
202
1086
444
2927
1.67
18.41
2.7
2.4
5.7
6.3
e6/l
0.43
394
2536
631
4555
1.57
17.93
2.6
2.4
61.2
56.8
u/l
0.47
573
4216
351
2189
1.74
17.82
2.3
2.4
12.9
14.0
umol/l
2.04
330
2010
245
1373
1.90
17.71
3.4
2.8
—
—
—
0
0
337
2110
1.72
16.79
1.9
1.7
—
—
—
0
0
209
1135
1.94
16.57
6.0
7.1
7.9
9.5
mmol/l
3.18
204
1080
1530
13502
1.61
16.39
20.8
13.5
13.6
13.5
%
0.63
1511
13182
1643
14766
1.70
16.31
6.1
5.5
38.9
39.5
mmol/mol
1.87
1565
13790
198
1065
1.96
16.13
2.4
2.2
0.2
0.2
g/l
0.13
186
976
224
1268
1.87
15.63
3.7
3.1
224.5
232.1
u/l
0.59
212
1188
725
5568
1.48
14.71
3.5
3.5
29.6
54.8
ng/l
1.47
481
3526
187
1030
1.90
14.17
4.5
3.9
75.5
86.5
ng/l
1.62
165
915
785
6162
1.46
14.06
2.0
1.9
96.0
95.9
pmol/l
0.00
414
3221
1711
15687
1.72
14.04
4.9
4.3
5.7
5.9
mmol/l
7.23
1624
14424
157
823
1.99
13.75
9.2
7.1
24.6
24.4
mmol/l
0.30
141
763
189
1060
1.87
13.53
2.7
2.3
10.4
10.7
g/l
0.58
166
972
639
4944
1.43
11.85
3.1
2.7
35.9
34.6
u/l
0.10
612
4701
49
167
2.98
11.18
1.1
1.1
—
—
—
0
0
234
1479
1.66
11.02
2.1
2.4
1.7
1.7
%
0.20
206
1294
1898
18182
2.43
10.97
26.1
16.5
253.9
253.1
e9/l
0.19
1876
17694
158
898
1.83
10.83
1.6
1.6
—
—
—
0
0
1898
18199
2.40
10.64
26.1
16.5
4.5
4.5
e12/l
0.66
1873
17671
14
17
8.29
10.62
1.1
1.1
—
—
—
0
0
313
2140
1.55
10.61
3.0
2.6
2.7
2.8
e6/l
0.02
168
1121
123
649
1.96
10.59
10.7
11.5
—
—
—
0
0
1898
18204
2.39
10.55
26.1
16.6
6.8
6.7
e9/l
0.69
1874
17677
516
3909
1.43
10.51
2.6
2.9
1262.2
1251.7
ng/l
0.01
445
3277
1898
18207
2.39
10.49
26.3
16.6
135.8
137.1
g/l
3.73
1887
17948
930
7796
1.37
10.32
3.6
3.4
0.0
0.0
estimate
0.02
241
1333
594
4632
1.41
10.23
5.3
3.6
1.7
1.8
ug/l
0.60
536
4198
172
1024
1.75
10.09
2.6
1.5
66.4
67.4
g/l
1.07
165
933
918
7707
1.36
9.96
3.6
3.4
0.0
0.0
estimate
0.50
241
1354
342
2416
1.50
9.92
3.2
2.0
2.4
2.4
mmol/l
0.80
298
2085
104
533
2.00
9.75
2.0
1.8
—
—
—
0
0
918
7728
1.35
9.69
4.8
4.6
0.0
0.0
estimate
0.50
244
1389
62
258
2.45
9.67
3.0
2.5
16.6
16.8
%
0.16
29
135
487
3712
1.42
9.44
1.4
1.3
1.1
1.6
u/ml
0.77
131
1040
96
491
2.00
9.07
1.8
1.7
—
—
—
0
0
1812
17213
1.71
8.84
11.4
8.5
28.5
26.4
u/l
1.46
1772
16590
446
3389
1.41
8.71
1.5
1.5
20.5
20.5
nmol/l
0.04
399
2907
72
337
2.18
8.60
1.4
1.2
—
—
—
0
0
362
2656
1.45
8.57
1.8
1.7
1095.4
1165.5
nmol/l
0.84
288
2040
325
2341
1.47
8.47
2.7
2.4
1.2
1.0
e6/l
0.21
180
1316
13
19
6.88
8.44
1.2
1.5
—
—
—
0
0
384
2857
1.43
8.42
3.3
3.5
238.6
565.8
ng/l
1.11
265
2083
144
868
1.71
8.10
3.5
3.4
5.0
5.2
kpa
1.64
129
805
520
4099
1.37
8.05
4.0
3.7
0.0
0.0
estimate
0.02
241
1357
12
17
7.10
8.00
1.1
1.1
—
—
—
0
0
35
120
2.95
7.98
1.1
1.1
—
—
—
0
0
541
4304
1.36
7.87
1.7
1.6
1.5
1.4
mmol/l
2.10
476
3653
1657
15504
1.45
7.87
4.3
3.8
1.4
1.3
mmol/l
3.87
1550
14345
1208
10777
1.32
7.74
3.5
2.9
45.9
43.0
u/l
0.71
1144
10087
134
803
1.72
7.70
1.4
1.5
—
—
—
0
0
71
346
2.09
7.68
1.6
1.7
—
—
—
0
0
136
826
1.69
7.45
3.4
3.3
1.7
1.7
mmol/l
0.02
92
605
353
2648
1.41
7.31
3.2
2.5
0.8
0.7
ug/l
0.34
249
1648
35
128
2.77
7.13
1.2
1.2
36.5
36.3
mg/l
0.02
29
99
224
1551
1.50
7.07
2.6
2.3
6.2
7.5
umol/l
0.74
194
1329
11
17
6.50
6.78
1.6
1.0
4.7
5.6
nmol/l
0.26
11
17
212
1471
1.49
6.62
1.7
1.7
—
—
—
0
0
178
1196
1.54
6.47
1.2
1.2
111.4
151.0
iu/ml
0.73
67
477
92
521
1.80
6.47
10.0
5.4
1.5
1.6
%
0.82
82
490
212
1479
1.49
6.45
1.8
1.7
—
—
—
0
0
1708
16191
1.43
6.42
4.8
4.3
4.7
4.7
mmol/l
0.26
1610
15149
1699
16095
1.42
6.37
4.7
4.2
1.4
1.5
mmol/l
9.03
1599
14984
184
1251
1.52
6.34
4.3
3.4
2.1
2.0
mmol/l
0.11
146
1016
24
76
3.18
6.30
4.0
1.1
515.6
221.6
u/ml
—
5
19
70
367
1.94
6.25
3.1
3.6
1.4
1.5
mg/l
0.23
63
332
1729
16444
1.44
6.21
5.2
4.7
2.8
2.8
mmol/l
0.95
1626
15311
36
144
2.53
6.20
5.5
3.0
1.2
1.1
%
0.15
29
110
23
72
3.22
6.15
1.1
1.1
—
—
—
0
0
707
6012
1.28
6.01
3.8
3.5
—
—
—
0
0
190
1317
1.49
5.97
2.1
2.3
29.9
39.8
u/l
1.76
165
1095
58
290
2.03
5.94
4.0
3.1
8.5
8.2
kpa
0.68
52
267
110
673
1.67
5.91
1.8
2.0
38.4
38.9
u/l
0.08
102
592
112
693
1.65
5.77
2.3
2.1
9851.6
4204.7
u/l
0.69
26
285
82
467
1.79
5.69
2.9
1.3
9.5
10.6
g/l
2.38
69
401
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
76
3.05
5.65
1.1
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
64
338
1.92
5.63
3.1
3.6
0.4
0.4
u/ml
0.29
42
195
459
3723
1.30
5.57
4.3
3.5
22.3
23.7
%
1.09
207
1628
86
502
1.75
5.50
2.8
1.4
—
—
—
0
0
86
502
1.75
5.50
2.8
1.4
7.1
7.3
g/l
0.50
65
377
86
502
1.75
5.50
2.8
1.4
3.8
3.8
g/l
0.05
64
361
81
466
1.77
5.45
2.9
1.4
2.8
3.0
g/l
1.19
63
370
75
422
1.81
5.43
2.0
2.0
2.2
4.7
iu/l
4.79
23
162
28
106
2.67
5.41
1.2
1.1
1.3
1.1
u/l
0.30
14
50
49
239
2.08
5.39
4.0
2.0
370.8
65.2
u/ml
0.84
38
185
118
761
1.59
5.17
1.6
1.6
—
—
—
0
0
73
414
1.79
5.17
3.1
1.4
0.4
0.3
g/l
0.12
66
364
10
19
5.29
5.04
1.0
1.1
—
—
—
0
0
71
405
1.78
4.95
2.0
2.2
9.6
11.0
mg/l
0.97
66
376
18
56
3.23
4.89
1.4
1.3
—
—
—
0
0
427
3484
1.29
4.89
1.8
1.7
1.1
1.0
mg/l
0.32
322
2591
79
470
1.71
4.77
1.5
1.8
0.2
0.2
g/l
0.85
74
448
1204
11060
1.23
4.65
3.4
3.2
—
—
—
0
0
52
276
1.91
4.57
3.2
3.0
34.5
37.1
umol/l
0.23
44
246
66
379
1.77
4.52
1.4
1.4
247.9
313.5
ug/g
2.57
38
215
166
1188
1.43
4.46
2.7
2.2
73.1
69.8
ml/min/173m2
0.43
60
458
27
112
2.43
4.39
1.0
1.1
1.8
7.4
nmol/l
—
9
20
24
95
2.55
4.30
7.0
3.1
53.1
53.1
%
0.00
14
63
8
9
8.92
4.28
8.8
1.0
18.4
14.5
u/ml
—
8
9
83
516
1.64
4.28
1.7
1.8
—
—
—
0
0
87
550
1.61
4.20
3.2
3.6
24.7
24.8
mmol/l
0.10
75
512
14
41
3.43
4.18
1.1
1.1
—
—
—
0
0
14
41
3.43
4.18
1.1
1.1
—
—
—
0
0
30
134
2.26
4.16
3.4
1.7
300.8
35.0
u/ml
0.42
30
119
66
391
1.71
4.09
3.2
1.3
38.3
38.3
g/l
0.01
59
336
14
42
3.35
4.04
1.1
1.2
—
—
—
0
0
255
1997
1.32
3.94
1.8
2.4
96.3
131.5
ug/g
1.31
192
1582
14
43
3.27
3.91
1.1
1.1
—
—
—
0
0
13
38
3.44
3.90
1.5
2.2
19.8
16.0
umol/l
0.46
13
38
8
11
7.30
3.86
1.0
1.1
—
—
—
0
0
467
3958
1.24
3.78
2.3
2.3
341.1
5346.9
umol/l
10.90
401
3440
13
39
3.35
3.76
1.1
1.1
—
—
—
0
0
48
267
1.82
3.71
1.5
1.6
—
—
—
0
0
37
189
1.98
3.69
1.3
1.3
—
—
—
0
0
16
56
2.87
3.63
1.5
1.3
—
—
—
0
0
72
455
1.60
3.53
2.5
1.7
3.0
1.6
ug/l
0.64
60
403
14
46
3.06
3.53
1.0
1.1
—
—
—
0
0
97
662
1.49
3.39
1.3
1.3
0.2
0.9
u/ml
—
9
62
9
18
5.02
3.37
1.1
1.1
—
—
—
0
0
56
338
1.68
3.30
4.3
3.0
24.5
24.8
mmol/l
0.27
49
302
9
19
4.75
3.24
1.1
1.3
—
—
—
0
0
16
60
2.68
3.23
2.8
2.1
—
—
—
0
0
45
258
1.76
3.19
1.2
1.3
—
—
—
0
0
45
258
1.76
3.19
1.2
1.3
—
—
—
0
0
83
556
1.51
3.19
1.5
1.8
1.5
1.5
g/l
0.04
72
480
47
274
1.73
3.15
2.7
3.5
4.0
4.2
e9/l
0.52
47
274
87
591
1.49
3.13
3.0
1.5
372.2
23.1
u/ml
0.49
82
565
16
62
2.59
3.04
1.3
1.1
0.3
0.3
g/l
0.76
11
50
17
68
2.51
3.04
1.0
1.4
—
—
—
0
0
15
57
2.64
2.96
1.2
1.2
110.8
107.9
%
0.15
15
48
56
350
1.62
2.92
3.5
1.4
41.6
41.1
mg/l
0.03
44
282
8
17
4.72
2.92
1.3
1.4
—
—
—
0
0
47
281
1.69
2.91
3.0
3.7
55.9
58.0
%
0.60
47
281
92
643
1.45
2.90
3.2
2.9
24.7
25.4
mmol/l
1.36
85
620
47
283
1.68
2.84
1.5
1.5
—
—
—
0
0
73
490
1.51
2.81
2.3
2.3
742.3
429.9
ug/l
0.49
68
455
8
18
4.46
2.79
1.1
1.1
125.1
105.2
%
—
8
18
26
131
2.00
2.75
1.1
1.1
—
—
—
0
0
6
10
6.01
2.70
1.0
1.1
—
—
—
0
0
55
351
1.58
2.66
3.5
1.4
32.7
48.6
mg/l
0.41
44
282
68
456
1.51
2.65
2.1
2.2
86.8
92.2
%
0.95
62
427
12
43
2.80
2.64
1.5
1.3
—
—
—
0
0
12
43
2.80
2.64
1.5
1.3
—
—
—
0
0
70
473
1.50
2.63
1.1
1.1
7.6
5.3
u/ml
—
7
64
45
274
1.66
2.63
1.6
1.6
—
—
—
0
0
375
3223
1.20
2.59
1.7
1.7
447.8
39119689.0
pmol/l
3.46
313
2725
16
68
2.36
2.55
2.7
2.0
11.4
11.7
%
—
5
35
253
2093
1.24
2.55
1.6
1.8
1.4
1.5
%
0.44
228
1853
6
11
5.47
2.54
1.0
1.1
—
—
—
0
0
15
62
2.43
2.54
2.1
1.2
246.6
188.2
u/l
0.65
15
62
14
56
2.51
2.53
1.0
1.1
—
—
—
0
0
19
88
2.17
2.51
1.3
1.5
—
—
—
0
0
29
159
1.84
2.44
1.2
1.5
—
—
—
0
0
28
154
1.83
2.34
1.5
1.3
—
—
—
0
0
53
347
1.54
2.34
1.4
2.3
0.8
0.8
nmol/l
0.06
48
287
7
18
3.90
2.25
7.9
6.3
5.8
6.5
mmol/l
—
7
18
5
9
5.57
2.21
1.0
2.9
—
—
—
0
0
32
187
1.72
2.21
1.6
1.6
—
—
—
0
0
23
121
1.91
2.21
1.2
1.7
—
—
—
0
0
22
114
1.94
2.20
1.1
1.2
—
—
—
0
0
22
114
1.94
2.20
1.1
1.2
—
—
—
0
0
111
844
1.33
2.19
4.5
2.8
132.2
131.6
g/l
0.09
105
819
21
108
1.95
2.15
1.0
1.2
—
—
—
0
0
43
274
1.58
2.15
1.3
1.5
101.8
104.6
u/ml
—
9
48
6
14
4.30
2.15
1.2
1.3
—
—
—
0
0
27
152
1.79
2.12
1.5
1.3
—
—
—
0
0
25
138
1.82
2.09
1.6
1.5
40.0
31.5
%
0.52
20
83
27
153
1.78
2.08
1.5
1.3
—
—
—
0
0
40
253
1.59
2.07
1.1
1.1
—
—
—
0
0
22
117
1.89
2.06
1.1
1.2
—
—
—
0
0
22
117
1.89
2.06
1.1
1.2
—
—
—
0
0
22
117
1.89
2.06
1.1
1.2
—
—
—
0
0
216
1800
1.22
2.06
22.6
24.1
1.2
1.3
inr
0.70
37
278
48
320
1.51
1.99
1.1
1.2
—
—
—
0
0
46
304
1.53
1.99
2.7
2.1
129.6
133.7
g/l
0.58
33
227
15
70
2.15
1.98
1.1
1.1
93.6
91.9
%
—
10
57
34
209
1.64
1.98
1.2
1.2
—
—
—
0
0
27
156
1.74
1.96
1.5
1.3
—
—
—
0
0
35
218
1.62
1.94
1.2
1.5
—
—
—
0
0
5
11
4.55
1.94
1.2
1.2
—
—
—
0
0
27
158
1.72
1.89
1.5
1.3
—
—
—
0
0
27
159
1.71
1.85
1.5
1.3
—
—
—
0
0
70
511
1.38
1.83
1.5
1.4
—
—
—
0
0
15
73
2.06
1.80
1.4
2.6
596.3
858.6
u/ml
0.56
15
73
52
361
1.45
1.80
1.2
1.2
19.0
46.5
u/ml
—
6
35
13
60
2.17
1.77
1.0
1.0
—
—
—
0
0
6
18
3.34
1.74
2.8
1.9
—
—
—
0
0
76
568
1.35
1.74
1.2
1.3
235.8
224.7
miu/ml
0.09
27
276
23
132
1.75
1.74
1.1
1.0
308.5
285.4
mg/l
0.68
23
120
33
211
1.57
1.68
1.3
1.2
—
—
—
0
0
219
1868
1.19
1.67
4.7
4.5
31.4
32.2
%
0.53
170
1287
19
104
1.84
1.67
1.2
1.1
—
—
—
0
0
8
31
2.59
1.66
1.3
1.1
—
—
—
0
0
7
25
2.81
1.65
1.1
1.2
—
—
—
0
0
60
439
1.38
1.59
1.2
1.3
11.7
7.3
u/ml
—
8
73
7
26
2.70
1.58
1.0
1.2
—
—
—
0
0
7
26
2.70
1.58
1.0
1.5
81.2
111.9
ng/l
—
7
26
55
398
1.39
1.56
2.3
3.0
—
—
—
0
0
32
208
1.55
1.54
1.3
1.3
—
—
—
0
0
59
434
1.37
1.52
1.2
1.2
2.3
2.6
u/ml
—
5
42
7
27
2.60
1.51
1.1
1.0
—
—
—
0
0
24
146
1.65
1.51
11.3
5.3
9.3
7.3
mmol/l
0.50
19
118
15
79
1.91
1.49
1.7
1.5
1.9
8.3
u/l
—
9
38
18
101
1.79
1.49
1.1
1.3
—
—
—
0
0
10
45
2.23
1.46
3.1
5.4
—
—
—
0
0
5
16
3.13
1.44
1.0
1.0
—
—
pmol/l
—
0
0
20
118
1.70
1.41
1.8
1.6
—
—
—
0
0
218
1894
1.17
1.38
8.2
6.0
—
—
—
0
0
76
966
0.78
1.36
1.5
1.5
—
—
—
0
0
311
2778
1.14
1.35
1.3
1.3
4.4
10.6
u/ml
3.30
121
1131
12
61
1.97
1.33
1.8
1.6
—
1631935.7
—
0
7
22
136
1.62
1.32
1.7
1.4
47.9
69.0
pmol/l
0.51
11
41
531
4909
1.11
1.30
2.9
3.2
7.8
7.8
mmol/l
0.06
456
4213
11
55
2.01
1.27
2.3
2.5
—
—
—
0
0
18
107
1.69
1.26
2.3
2.2
—
—
—
0
0
16
92
1.75
1.25
1.1
1.0
—
—
—
0
0
35
245
1.44
1.23
2.2
1.7
—
—
—
0
0
21
131
1.61
1.23
1.1
1.5
0.9
1.4
promille
0.92
15
104
8
38
2.11
1.18
1.4
1.1
—
—
—
0
0
321
2902
1.13
1.17
1.3
1.3
24.6
33.8
iu/ml
1.13
80
904
35
249
1.41
1.15
1.1
1.1
121.3
115.9
%
0.43
28
230
1545
15094
1.11
1.15
18.4
12.2
40.2
40.3
%
0.18
1152
11272
20
126
1.59
1.14
1.1
1.2
—
—
—
0
0
23
150
1.54
1.14
1.4
1.4
9.6
12.3
mmol/l
—
6
38
12
65
1.85
1.13
1.3
1.1
—
—
—
0
0
5
114
0.44
1.12
1.2
1.5
—
—
—
0
0
136
1159
1.19
1.12
2.8
2.9
122.8
182.7
ng/l
1.96
122
1056
41
302
1.37
1.11
1.1
1.3
148.5
244.6
u/ml
3.36
22
190
140
1628
0.85
1.09
1.7
1.7
—
—
—
0
0
12
67
1.80
1.04
2.2
3.8
77.4
143.9
umol/l
—
7
44
57
721
0.78
1.03
1.8
1.7
3.3
4.4
mg/l
0.48
41
494
20
130
1.54
1.02
1.1
1.3
—
—
—
0
0
14
83
1.69
1.01
1.0
1.0
—
—
—
0
0
7
35
2.00
1.00
1.7
2.2
—
—
—
0
0
150
1305
1.16
0.98
1.8
1.9
—
—
—
0
0
7
36
1.95
0.97
3.1
2.6
—
—
—
0
0
7
36
1.95
0.97
6.3
3.1
—
—
—
0
0
7
36
1.95
0.97
3.1
2.6
—
—
—
0
0
45
346
1.31
0.95
1.2
1.2
—
10.9
—
0
5
51
399
1.29
0.95
1.4
1.4
—
—
—
0
0
7
37
1.90
0.94
3.0
1.7
—
—
—
0
0
7
37
1.90
0.94
3.0
1.7
—
—
—
0
0
7
37
1.90
0.94
3.1
1.8
—
—
—
0
0
40
304
1.32
0.92
1.3
1.3
—
—
—
0
0
20
134
1.50
0.91
1.8
1.5
—
—
—
0
0
120
1034
1.17
0.90
1.6
1.8
—
—
—
0
0
64
519
1.24
0.90
1.8
2.1
—
—
—
0
0
145
1269
1.15
0.90
2.2
2.4
6.7
7.7
ug/l
0.26
121
1127
222
2011
1.12
0.82
2.0
2.0
—
—
—
0
0
0
24
0.00
0.79
0.0
2.4
—
0.8
—
0
24
51
627
0.81
0.77
1.5
1.4
—
—
—
0
0
10
59
1.70
0.75
1.2
1.5
—
—
—
0
0
10
59
1.70
0.75
1.2
1.5
—
—
—
0
0
5
24
2.09
0.74
4.0
3.7
—
—
—
0
0
27
201
1.35
0.74
1.2
1.1
1.4
1.5
g/l
0.08
27
181
9
54
1.67
0.74
1.0
1.0
—
—
—
0
0
6
108
0.55
0.72
1.5
1.3
—
—
—
0
0
30
230
1.31
0.69
1.1
1.1
—
—
—
0
0
22
161
1.37
0.68
1.2
1.4
—
—
—
0
0
22
161
1.37
0.68
1.9
2.4
16.0
24.5
mg/l
—
6
45
60
503
1.20
0.66
1.8
1.7
—
—
—
0
0
243
2247
1.09
0.64
2.1
2.1
—
—
—
0
0
27
207
1.31
0.63
1.3
1.1
—
—
—
0
0
33
261
1.27
0.62
1.1
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
2.3
—
1.4
—
0
16
8
52
1.54
0.59
2.8
1.6
—
—
—
0
0
8
52
1.54
0.59
2.8
1.6
—
—
—
0
0
8
52
1.54
0.59
2.8
1.6
—
—
—
0
0
8
52
1.54
0.59
2.8
1.6
—
—
—
0
0
38
464
0.82
0.58
1.3
1.6
—
—
—
0
0
8
53
1.51
0.58
1.6
1.3
—
—
—
0
0
8
53
1.51
0.58
2.4
1.4
12.0
8.7
ug/l
—
8
53
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
69
599
1.16
0.54
1.3
1.5
—
—
—
0
0
6
100
0.60
0.51
1.5
1.2
—
—
—
0
0
6
40
1.50
0.51
1.0
1.2
—
83.5
—
0
13
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
6
40
1.50
0.51
1.0
1.2
—
71.1
—
0
12
30
242
1.24
0.51
1.0
1.0
1.5
2.6
u/ml
0.77
16
117
14
101
1.39
0.49
1.4
1.3
—
—
—
0
0
24
191
1.26
0.46
1.3
1.4
—
—
—
0
0
29
353
0.82
0.46
1.1
1.5
—
—
—
0
0
18
138
1.31
0.45
1.2
1.1
—
—
—
0
0
14
103
1.36
0.45
2.1
1.4
—
—
—
0
0
14
103
1.36
0.45
2.1
1.4
—
—
—
0
0
14
103
1.36
0.45
2.1
1.4
—
—
—
0
0
7
50
1.40
0.45
1.0
1.3
—
—
—
0
0
10
69
1.45
0.44
1.2
1.4
—
—
—
0
0
51
442
1.16
0.43
1.1
1.1
—
—
—
0
0
12
87
1.38
0.42
1.2
1.4
—
694.0
—
0
10
48
551
0.87
0.41
1.4
1.5
—
—
—
0
0
18
227
0.79
0.40
1.2
1.2
—
—
—
0
0
44
506
0.87
0.39
1.4
1.4
—
—
—
0
0
44
505
0.87
0.38
1.4
1.4
—
—
—
0
0
44
504
0.87
0.37
1.4
1.4
—
—
—
0
0
5
37
1.35
0.37
2.0
6.9
63.8
76.8
%
—
5
31
44
503
0.87
0.37
1.4
1.4
—
—
—
0
0
34
292
1.17
0.34
1.6
1.7
—
—
—
0
0
51
572
0.89
0.33
1.5
1.5
—
—
—
0
0
52
464
1.12
0.32
1.3
1.3
—
—
—
0
0
41
360
1.14
0.32
2.1
1.6
10570.1
12839.2
e6/l
0.17
32
273
11
83
1.33
0.32
1.0
1.7
0.5
4.5
u/field
—
6
67
20
241
0.83
0.31
3.1
3.2
0.8
0.8
nmol/l
0.09
14
184
8
63
1.27
0.27
1.0
1.8
—
—
—
0
0
8
63
1.27
0.27
1.0
1.8
—
—
—
0
0
27
233
1.16
0.27
2.8
2.1
11.0
4.5
umol/l
0.65
22
160
8
65
1.23
0.27
1.6
1.3
—
—
—
0
0
70
644
1.09
0.26
1.7
1.9
—
—
—
0
0
5
75
0.67
0.25
1.6
2.0
17.2
125.8
ug/l
—
5
66
22
256
0.86
0.25
1.2
1.1
—
—
—
0
0
15
123
1.22
0.25
1.3
1.1
—
4.1
—
0
8
16
133
1.20
0.24
1.1
1.0
—
—
—
0
0
269
2784
0.96
0.23
1.4
1.5
—
—
—
0
0
14
115
1.22
0.23
1.4
1.3
—
—
—
0
0
11
88
1.25
0.22
1.0
1.7
—
—
—
0
0
10
79
1.27
0.22
1.7
2.0
—
—
—
0
0
14
116
1.21
0.22
1.4
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
29
258
1.13
0.21
1.6
1.2
15.1
5.4
u/ml
0.76
12
117
38
418
0.91
0.20
1.6
1.7
—
—
—
0
0
15
127
1.18
0.19
1.7
1.4
0.9
1.0
g/l
0.07
15
127
21
238
0.88
0.18
1.2
1.3
7.7
7.4
mmol/l
0.18
16
173
12
100
1.20
0.18
1.1
1.7
—
—
—
0
0
37
402
0.92
0.16
2.6
2.3
179.8
111.4
ug/min
0.34
15
261
329
3219
1.03
0.15
1.7
1.6
—
—
—
0
0
10
119
0.84
0.15
8.4
12.9
858.1
848.2
nmol/l
—
10
114
16
141
1.14
0.14
1.1
1.2
0.2
0.6
u/ml
—
7
65
24
218
1.10
0.13
1.3
1.4
—
—
—
0
0
9
109
0.82
0.13
1.0
1.4
—
—
—
0
0
36
336
1.07
0.12
3.1
3.5
24.5
27.1
mg/l
0.20
20
212
55
525
1.05
0.10
1.6
1.6
0.1
0.2
iu/ml
0.08
11
98
478
4728
1.01
0.09
3.7
4.0
8.9
8.8
mg/mmol
0.02
299
3028
30
283
1.06
0.08
1.1
1.1
10.1
1877.4
iu/ml
—
10
70
8
75
1.07
0.07
1.3
1.1
1180.6
1593.9
miu/ml
—
8
75
16
147
1.09
0.07
1.4
1.6
7.9
7.6
mmol/l
—
7
90
7
85
0.82
0.07
1.3
1.4
17.0
34.7
nmol/l
—
7
71
9
100
0.90
0.06
16.0
12.4
0.7
0.7
mmol/l
—
9
94
91
889
1.02
0.06
1.0
1.0
—
—
—
0
0
34
355
0.96
0.06
1.1
1.1
1.4
1.9
u/ml
0.22
13
149
28
269
1.04
0.04
1.5
1.2
2.3
3.2
u/ml
—
9
100
48
468
1.03
0.03
1.2
1.1
—
—
—
0
0
14
132
1.06
0.02
4.3
3.6
—
—
—
0
0
25
258
0.97
0.02
1.6
1.6
—
—
—
0
0
12
127
0.94
0.01
2.1
2.3
617.0
605.2
ml
—
6
90
87
878
0.99
0.01
1.3
1.4
—
—
—
0
0
347
3463
1.00
0.00
3.7
3.8
1.0
1.0
kg/l
1.34
45
489
13
129
1.01
0.00
1.2
2.2
0.9
2.0
u/field
—
7
61
13
126
1.03
0.00
1.1
1.1
—
—
—
0
0
47
466
1.01
0.00
1.2
1.1
—
—
—
0
0
17
168
1.01
0.00
1.2
1.4
—
—
—
0
0
10
97
1.03
0.00
1.4
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
4.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
8.7
—
0
7
0
9
0.00
0.00
0.0
2.8
—
4.1
—
0
9
8
80
1.00
0.00
1.0
1.1
158.3
219.0
iu/ml
—
8
80
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_PITUITARY_CRANIPHAR_EXALLC – Benign neoplasm: Pituitary gland, craniopharyngeal duct
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).